10 February 2022 : Clinical Research
A Single-Center, Randomized, Double-Blind Study of 94 Patients Undergoing Surgery for Cerebral Glioma to Compare Postoperative Thromboprophylaxis with and without Rivaroxaban
DOI: 10.12659/MSM.934341
Med Sci Monit 2022; 28:e934341